HOME >> MEDICINE >> NEWS
Gene expression pattern predicts multiple drug resistance, treatment failure in pediatric leukemia

The discovery of a specific pattern of gene expression linked to multiple-drug resistance of leukemic cells is giving researchers crucial information into why standard therapies fail to cure some children with acute lymphoblastic leukemia (ALL). This finding, from investigators at St. Jude Children's Research Hospital, could lead to development of drugs that would overcome that resistance.

This new finding helps to explain why about 20 percent of children with ALL, the most common form of childhood cancer, are not cured with the same drug therapy that cures the remaining 80 percent of children with this disease. A report on the study that produced this new information appears in the April issue of Cancer Cell.

Drug resistance is a major cause of treatment failure, and the biochemical mechanisms responsible for de novo resistance are largely unknown. De novo resistance means that the resistance is "built into" the leukemic cells through a particular pattern of gene expression, rather than acquired through genetic mutation during treatment. Cross-resistance to multiple drugs suggests a poor prognosis and likely involves biochemical mechanisms that are different from those linked to single-drug resistance.

The investigators sought to identify the specific pattern of gene expression in ALL cells that is linked to de novo cross-resistance to four widely used antileukemic agents, and to determine how those genes affected treatment outcome.

"The identification of a particular genetic expression pattern linked to cross-resistance takes us a significant step forward in understanding why treatment fails to cure certain children who initially looked like good candidates for standard chemotherapy," said William E. Evans, Pharm.D., St. Jude director and member of St. Jude Pharmaceutical Sciences. "The results also give us crucial information into treatment failure that could help us design more effective treatments for the children our current treatment
'"/>

Contact: Carrie Strehlau
Carrie.Strehlau@stjude.org
901-495-3306
St. Jude Children's Research Hospital
18-Apr-2005


Page: 1 2 3

Related medicine news :

1. XDx presents success with AlloMap molecular expression testing to international transplant community
2. Gene expression test reveals ER and HER-2 status of breast tumors
3. Chronic alcohol exposure can affect brain protein expression
4. Core needle biopsy gives an accurate picture of gene expression in whole tumor
5. Different gene-expression predictors of breast cancer agree, UNC study shows
6. Gene expression in labor; and more -- press release from PLoS Medicine
7. Low-glycemic load diet may be more effective for dieters with certain insulin response patterns
8. Puerto Rican and African-American children show different patterns of asthma care
9. Abnormal pattern of brain development in premature babies
10. Study assesses relationship between conflicts of interest and voting patterns at FDA meetings
11. Medication plus oral contraceptive may improve female pattern hair loss

Post Your Comments:
(Date:5/19/2013)... Beach, Florida (PRWEB) May 19, 2013 ... and market access, is pleased to unveil a new ... show environment that provides a powerful array of real-time ... partners in the US and abroad. , HE-Xpo is ... will offer attendees the look and feel of being ...
(Date:5/18/2013)... COOLA, British Columbia (PRWEB) May 19, 2013 ... to Cooking” (published by iUniverse) , author Janet Hall Svisdahl’s ... delectable world recipes sure to make even the pickiest ... living peacefully, pleasurably and prayerfully,” she explains. , Found ... Spirit” are a wide range of delicious recipes, from fast ...
(Date:5/18/2013)... 2013 Also known as bariatric ... weight loss surgery that guarantees patients long-term weight loss. ... wishes to give readers a brief tutorial on this ... school at New York City’s Mount Sinai School of ... undertook a fellowship in Minimally Invasive Bariatric Surgery. He ...
(Date:5/18/2013)... -- Just a few extra cups of coffee each ... liver disease known as primary sclerosing cholangitis (PSC), a ... in Rochester, Minn., found that drinking coffee was associated ... can lead to cirrhosis of the liver, liver failure ... a cause-and-effect relationship. "While rare, PSC has ...
(Date:5/18/2013)... 2013 In a May 14, 2013 ... Mastectomy After Discovering Cancer Gene,” Fox News reported the ... learning that she carried a gene that doctors estimated ... and a 50 percent risk of ovarian cancer (go ... May 16, 2013 with a blog post entitled “A ...
Breaking Medicine News(10 mins):Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:Everything You Need to Know About Lap Band Surgery 2Health News:Everything You Need to Know About Lap Band Surgery 3Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2
(Date:5/17/2013)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today announced ... Global Healthcare Conference in New York . ... at 11 a.m. Eastern Time. To listen to the live ... Investor Relations section of the Company,s Web site at ... after the event. About Orexigen® Therapeutics Orexigen ...
(Date:5/17/2013)... , May 17, 2013  Sony Biotechnology Inc. ... SP6800 Spectral Analyzer (SP6800).  Sony will be exhibiting and ... will be held at the San Diego ... California , from May 20 - 22.  ... analytical system, incorporating commercial audio-visual technologies into new and ...
(Date:5/17/2013)... -- ConvaTec today announced that it will report its 2013 first quarter earnings ... and Ed Borkowski , CFO, will host an analyst ... To participate in the conference call within the U.S. and ... the conference call outside the U.S. and Canada , ... Participants should dial in 10 minutes prior to the start of ...
Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
Cached News: